HIF1A and Alzheimer disease: These findings suggest that iron chelators activate the P38 MAPK signaling pathway to upregulate HIF-1α, increase the expression of HIF-1α-dependent genes, and participate in the pathological process of AD, with the mechanism potentially promoting the redistribution of iron rather than its removal for neuroprotective effects.